Zimmer Biomet wins three awards at the Healthcare Asia Medtech Awards 2026

The awards recognize innovations in infection measurement, AI-driven recovery and surgeon engagement across the Asia-Pacific region.

SINGAPORE, March 27, 2026 /PRNewswire/ — Zimmer Biomet (NYSE and SIX: ZBH), a global leader in medical technology, today announced that it has received three awards at the Healthcare Asia Medtech Awards 2026, recognizing the company’s innovations in orthopedic product development, digital health and surgeon engagement.

Zimmer Biomet took home honors in the following categories:

• Orthopedic Product Innovation Award for his new iodine-treated hip implant;
• Australia’s Digital Innovation of the Year for its WalkAI knee replacement recovery monitoring platform; And
• Marketing and communications initiative of the year in Thailand for its You’ll Be Back awareness campaign featuring Arnold Schwarzenegger as the company’s motion director.

“These awards reflect the strength of Zimmer Biomet’s innovation and the relevance of our solutions in the Asia-Pacific region,” said Sang Yi, president of the Asia-Pacific Group. “From combating the risk of infection with advanced implant technologies to enabling more proactive, data-driven recoveries and strengthening how we engage surgeons, we are focused on solving the region’s biggest healthcare challenges and improving patient outcomes.”

Advancing measures against infections in orthopedics

Zimmer Biomet received the Orthopedic Product Innovation Award for its iodine technology-treated implants, the iTaperloc Complete and the iG7 Hip System. These implants are designed to inhibit bacterial adhesion^1,2 and reduce the risk of periprosthetic joint infection, a serious complication affecting approximately 1-2% of primary procedures.³

Iodine, a biocompatible nutrient, helps prevent biofilm formation without contributing to antibiotic resistance.^4,5 The technology has received regulatory recognition globally, including approval from the Japanese Ministry of Health, Labor and Welfare in September 2025 and breakthrough device designation from the U.S. Food and Drug Administration in October 2025.

Advancing recovery with AI

Zimmer Biomet’s WalkAI platform received the Digital Innovation of the Year – Australia award. The app uses artificial intelligence to analyze real-world mobility data and predict a patient’s walking speed within 90 days of total knee replacement surgery.

By identifying gaps in recovery between days 15 and 40 after surgery, a typically “touchless” period of care, WalkAI is designed to flag patients who may not recover as expected and enable earlier clinical intervention. This additional visibility allows surgeons to prioritize patients who may require closer monitoring or rehabilitation adjustments, helping to reduce the risk of complications.

The platform is currently used by more than 180 surgeons in Australia and New Zealand to care for more than 20,000 knee replacement patients, demonstrating strong clinical adoption and scalability in practice.

Raise awareness of movement and treatment options

The Marketing and Communications Initiative of the Year – Thailand award went to the “You’ll Be Back” campaign, which leverages Zimmer Biomet’s partnership with Arnold Schwarzenegger as the company’s motion director.

Launched at the annual conference of the Royal College of Orthopedic Surgeons of Thailand, the campaign was tailored specifically to a highly regulated market through close collaboration between the company’s communications, marketing, legal and compliance teams. Rather than focusing on product promotion, the initiative focused on the importance of movement and aimed to raise awareness among pain sufferers of the treatment options available.

The message resonated strongly in moving conversations beyond products to recovery, longevity and quality of life. The campaign significantly increased engagement, with booth interactions tripling year on year and strong resonance among surgeons.

The Healthcare Asia Medtech Awards recognize leading companies and innovations in the region, highlighting advancements in medical devices, digital health and patient care solutions.

About Zimmer Biomet

Zimmer Biomet is a global leader in medical technology with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With more than 90 years of trusted leadership and proven expertise, Zimmer Biomet is able to provide the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, operations in over 25 countries and sales in over 100 countries or to join our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X/Twitter at www.twitter.com/zimmerbiomet.

Zimmer Biomet:

Show original content:https://www.prnewswire.com/apac/news-releases/zimmer-biomet-wins-trois-awards-at-healthcare-asia-medtech-awards-2026-302726585.html

SOURCE Immer Biomet Holdings, Inc.

Source: PR Newswire